These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39340750)

  • 21. A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.
    Robinson A; Spencer A; Moffatt P
    Med Decis Making; 2015 Apr; 35(3):341-50. PubMed ID: 25349189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valuing SF-6D Health States Using a Discrete Choice Experiment.
    Norman R; Viney R; Brazier J; Burgess L; Cronin P; King M; Ratcliffe J; Street D
    Med Decis Making; 2014 Aug; 34(6):773-86. PubMed ID: 24025661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?
    Mulhern B; Norman R; Lorgelly P; Lancsar E; Ratcliffe J; Brazier J; Viney R
    Pharmacoeconomics; 2017 Apr; 35(4):439-451. PubMed ID: 27873226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2.
    Poder TG; Fauteux V; He J; Brazier JE
    Value Health; 2019 Jul; 22(7):837-842. PubMed ID: 31277832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EQ-5D-5L and SF-6Dv2 health utilities scores of diffuse large B-cell lymphoma patients in China.
    Li M; Fang B; Gu H; Jiang Y
    Health Qual Life Outcomes; 2024 Sep; 22(1):80. PubMed ID: 39300432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues.
    Bansback N; Hole AR; Mulhern B; Tsuchiya A
    Soc Sci Med; 2014 Aug; 114(100):38-48. PubMed ID: 24908173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in health utilities between cancer patients and the general population: The case of Quebec using the SF-6Dv2.
    Touré M; Poder TG
    Soc Sci Med; 2024 Jun; 351():117001. PubMed ID: 38805836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks.
    Che M; Pullenayegum E
    Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff.
    Comans TA; Nguyen KH; Ratcliffe J; Rowen D; Mulhern B
    Pharmacoeconomics; 2020 Aug; 38(8):871-881. PubMed ID: 32314315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SF-6Dv2 preference value set for health utility in food allergy.
    Dufresne É; Poder TG; Samaan K; Lacombe-Barrios J; Paradis L; Des Roches A; Bégin P
    Allergy; 2021 Jan; 76(1):326-338. PubMed ID: 32533705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?
    Augestad LA; Rand K; Luo N; Barra M
    Value Health; 2020 Apr; 23(4):487-494. PubMed ID: 32327166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France.
    Smith AB; Hanbury A; Whitty JA; Beitia Ortiz de Zarate I; Hammes F; de Pouvourville G; Buesch K
    Patient Relat Outcome Meas; 2022; 13():21-30. PubMed ID: 35115856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
    Kouakou CRC; He J; Poder TG
    Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciding Between SF-6Dv2 Health States: A Think-Aloud Study of Decision-Making Strategies Used in Discrete Choice Experiments.
    Broderick L; Bjorner JB; Lauher-Charest M; White MK; Kosinski M; Mulhern B; Brazier J
    Value Health; 2022 Dec; 25(12):2034-2043. PubMed ID: 36064513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.
    Xie S; Wang D; Wu J; Liu C; Jiang W
    Health Qual Life Outcomes; 2022 Jun; 20(1):96. PubMed ID: 35710429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment.
    Hettiarachchi RM; Arrow P; Senanayake S; Carter H; Brain D; Norman R; Tonmukayawul U; Jamieson L; Kularatna S
    Eur J Health Econ; 2023 Nov; 24(8):1285-1296. PubMed ID: 36394684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency.
    Smith AB; Hanbury A; Whitty JA; Buesch K
    Patient Relat Outcome Meas; 2021; 12():97-106. PubMed ID: 34012310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
    Whitty JA; Ratcliffe J; Chen G; Scuffham PA
    Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Norms for SF-6Dv2 and EQ-5D-5L in China.
    Xie S; Wu J; Xie F
    Appl Health Econ Health Policy; 2022 Jul; 20(4):573-585. PubMed ID: 35132573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec.
    Touré M; Sfairy SM; Bédard SK; McFadden N; Hanel R; Lemay F; He J; Pavic M; Poder TG
    Qual Life Res; 2024 Jun; 33(6):1605-1619. PubMed ID: 38642218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.